The Journal of the Korean Rheumatism Association 2006; 13(2): 107-115
Published online June 30, 2006
© Korean College of Rheumatology
김재왕·김진석*
제주대학교 의과대학 피부과학교실, 내과학교실*
Correspondence to : Jinseok Kim
Objective: Lupus erythematosus panniculitis (LEP) is a rare subtype of chronic cutaneous LE. Until now, a few studies about the clinico-histopathological data of LEP have been conducted in Korea. The aim of this study was to investigate clinical, serological, and histopathologic features of LEP. Methods: The clinical survey was retrospectively performed through the available medical records in 15 cases with LEP. The histopathologic, serologic and clinical findings were included in this analysis. Results: LEP occurred primarily in females (F:M=4:1). The mean age at diagnosis was 37.5 years. 20% (3/15) of the patients was associated with SLE. DLE was accompanied with LEP in 26.6% (4/15). The predilectional sites were as follows in order: upper limbs (33.3%), lower limbs (20%), trunk (26.6%), buttock (13.3%) and face (6.6%). The fluorescent antinuclear antibody (FANA) was positive in 46% (7/15) of all cases. The main histopathologic characteristics of LEP were lymphocytic lobular panniculitis (100%), hyaline degeneration (86.6%), lymphoid aggregates (60%), mucin deposition (60%), lymphocytic vasculitis (40%). The treatment included anti-malarial agents, systemic corticosteroid, dapsone, intralesional triamcinolone injection. Although significant remission was proven in most cases (86.6%) of LEP, they represented a chronic relapsing course (83.3%).Conclusion: LEP is a chronic inflammatory disease of subcutaneous adipose tissue that candevelop during the course of SLE. Evaluation of patients suspected of having LE panniculitis should include a complete history taking and physical examination as well as serologic studies, determination of peripheral blood counts, and tests of renal function.
Keywords Systemic lupus erythematosus, Lupus panniculitis
The Journal of the Korean Rheumatism Association 2006; 13(2): 107-115
Published online June 30, 2006
Copyright © Korean College of Rheumatology.
김재왕·김진석*
제주대학교 의과대학 피부과학교실, 내과학교실*
Jae-Wang Kim, M.D., Jinseok Kim, M.D.*
Departments of Dermatology and Internal Medicine*, College of Medicine, Cheju National University, Jeju, Korea
Correspondence to:Jinseok Kim
Objective: Lupus erythematosus panniculitis (LEP) is a rare subtype of chronic cutaneous LE. Until now, a few studies about the clinico-histopathological data of LEP have been conducted in Korea. The aim of this study was to investigate clinical, serological, and histopathologic features of LEP. Methods: The clinical survey was retrospectively performed through the available medical records in 15 cases with LEP. The histopathologic, serologic and clinical findings were included in this analysis. Results: LEP occurred primarily in females (F:M=4:1). The mean age at diagnosis was 37.5 years. 20% (3/15) of the patients was associated with SLE. DLE was accompanied with LEP in 26.6% (4/15). The predilectional sites were as follows in order: upper limbs (33.3%), lower limbs (20%), trunk (26.6%), buttock (13.3%) and face (6.6%). The fluorescent antinuclear antibody (FANA) was positive in 46% (7/15) of all cases. The main histopathologic characteristics of LEP were lymphocytic lobular panniculitis (100%), hyaline degeneration (86.6%), lymphoid aggregates (60%), mucin deposition (60%), lymphocytic vasculitis (40%). The treatment included anti-malarial agents, systemic corticosteroid, dapsone, intralesional triamcinolone injection. Although significant remission was proven in most cases (86.6%) of LEP, they represented a chronic relapsing course (83.3%).Conclusion: LEP is a chronic inflammatory disease of subcutaneous adipose tissue that candevelop during the course of SLE. Evaluation of patients suspected of having LE panniculitis should include a complete history taking and physical examination as well as serologic studies, determination of peripheral blood counts, and tests of renal function.
Keywords: Systemic lupus erythematosus, Lupus panniculitis
Bong-Woo Lee, M.D., Eui-Jong Kwon, M.D., Ji Hyeon Ju, M.D., Ph.D.
J Rheum Dis -0001; ():So-Young Bang, M.D., Ph.D., Seung Cheol Shim, M.D., Ph.D.
J Rheum Dis 2024; 31(4): 200-211Alhanouf Adnan Alsharif, M.B.B.S., Abdulaziz Marzouq Almutairi, M.D., Emtenan Badar Basahl, M.B.B.S., Abdulaziz Abdulllah Alshathri, M.D., Jameela Abdulaziz Kari, M.D., Mohammed Ahmad Shalaby, M.D., Mohammed Ahmad Nashawi, M.D.
J Rheum Dis 2025; 32(1): 57-62